3629 results for «788»

Filter By

3629 results

TRISCEND, ACURATE neo2, the LuX-Valve System: Top Late-Breaking Trials from PCR London Vaves 2022

27 Nov 2022 – From PCR London Valves 2022

Discover a selection of PCR London Valves 2022 Late-Breaking Trial submissions and learn more about the latest evidence evidence concerning new transcatheter valve devices, emerging innovative devices as well as highlighted content from the EuroIntervention journal.

Top Late-Breaking Trials

CLASP II TR, TriBAND, bRIGHT: Late-Breaking Trials on tricuspid intervention

27 Nov 2022 – From PCR London Valves 2022

Discover a selection of PCR London Valves 2022 Late-Breaking Trial submissions in this session: the CLASP II TR on transcatheter tricuspid valve repair, the TriBAND study one-year outcomes on transcatheter tricuspid annular reduction, and the bRIGHT trial on real-world outcomes for TEER.

Tricuspid - Late-Breaking Trials

Rapid-fire abstracts: session 3

27 Nov 2022 – From PCR London Valves 2022

Everything you need to know about the OPERA-TAVI registry, the UK TAVI registry, the TAVI-COMIC study, or the external validation of the TRI-SCORE in patients undergoing isolated tricuspid valve surgery, among others, can be found in this session of PCR LV 2022.

Rapid-fire abstracts: session 3

Mitral valve in mitral annular calcification (MAC) - Recorded case

27 Nov 2022 – From PCR London Valves 2022

A 53-year-old male with a history of SAVR (Perimount 23) 10 years ago and chest radiotherapy (lymphoma) presents a severe mitral stenosis (MAC) with preserved LV function and impaired RV function.
On sentinel cerebral protection, the operators perform a transseptal puncture with electrifying a non-stiff guide wire,...

Recorded case: Mitral valve in MAC

The multidisciplinary structural heart team - How do we include the patient

27 Nov 2022 – From PCR London Valves 2022

Consult this session on the multidisciplinary structural heart team to learn more about the evolving role of the team and how this affects decision making, to discover why patient advocacy and partnership is vital within the team, as well as to identify potential barriers and enablers of the future...

The multidisciplinary structural heart team - How do we include the patient

TAVI: Late-Breaking Trials and Innovations

27 Nov 2022 – From PCR London Valves 2022

Consult this session to discover a selection of PCR London Valves 2022 Late-Breaking Trial submissions, and learn more about the early safety and performance of the Vienna TAVI system, the new-generation transcatheter aortic valve platforms performance in native pure aortic regurgitation, and more!

TAVI: Late-Breaking Trials and Innovations

TAVI: vascular access and bleeding complications

27 Nov 2022 – From PCR London Valves 2022

To learn more about FAST ACCESS Pilot, transfemoral-only TAVI, next-generation suture-mediated closure device in TAVR, or percutaneous axillary TAVI under local anaesthesia, among others, watch this session from PCR LV 2022!

TAVI: vascular access and bleeding complications

Rapid-fire abstracts: session 4

27 Nov 2022 – From PCR London Valves 2022

In this PCR LV 2022 session dedicated to TAVI, take advantage of the 7 abstracts to learn more about the impact of TAVI for pure regurgitation on the severity of concomitant mitral regurgitation, the deformation of transcatheter heart valve and haemodynamics after aortic ViV, and much...

Rapid-fire abstracts: session 4

Paravalvular leak closure

27 Nov 2022 – From PCR London Valves 2022

5 specific cases are proposed in this PCR LV 2022 session dedicated to PVL, including concomitant ViV TAVI and paravalvular leak closure, transapical mitral paravalvular leak closure in a young patient, or transcatheter mitral ViV implantation for paravalvular leak. Watch the videos now to find out more!

Paravalvular leak closure

Tricuspid and pulmonary interventions

27 Nov 2022 – From PCR London Valves 2022

Watch this series of cases presented at PCR LV 2022 and learn more about Alagille syndrome, how to treat a significant right-to-left shunt after bicaval valve implantation, or analyze transcatheter pulmonary valve implantation in tetralogy of Fallot, among others.

Tricuspid and pulmonary interventions

Transcatheter primary mitral regurgitation repair and tricuspid replacement - LIVE case

28 Nov 2022 – From PCR London Valves 2022

  • Part 1: Primary MR repair (recorded case)
    An 89-year-old male with atrial fibrillation, severe primary MR (prolapse A1-A2) with a preserved LV function. The operators implant 1 Pascal ACE, on general anaesthesia, guided by TEE.
  • Part 2: Tricuspid valve in valve (Live case)
    A 52-year-old female, with diabetes and...
Transcatheter intervention for mitral and tricuspid valve disease: state of the art

Challenging scenarios: acute coronary obstruction

28 Nov 2022 – From PCR London Valves 2022

Discover some challenging case of acute coronary obstruction in these presentations, and learn more about the anatomical and procedural factors that predict this complication during TAVI, the available strategies for coronary protection during TAVI, as well as the leaflet laceration techniques to prevent TAVI-induced coronary obstruction.

Challenging scenarios: acute coronary obstruction

Is frailty still relevant after 20 years of TAVI?

28 Nov 2022 – From PCR London Valves 2022

Consult this session to gain further knowledge of the frailty syndrome, to understand its relevance in today's patient population and to learn how to measure it using validated tools.

Is frailty still relevant after 20 years of TAVI?

Mitral - Late-Breaking Trials and Innovations

28 Nov 2022 – From PCR London Valves 2022

Consult this session to discover a selection of late-breaking trials presented during PCR LV 2022: TENDyne European expeRience registry, CLASP IID trial, EXPAND G4, and much more!

Mitral - Late-Breaking

Imaging for mitral valve interventions

28 Nov 2022 – From PCR London Valves 2022

Thanks to this PCR LV 2022 session, find out more about outcome of patients undergoing transcatheter edge-to-edge mitral valve repair with HFpEF diagnosis.

Imaging for mitral valve interventions

Valve-in-valve TAVI: Session 2

28 Nov 2022 – From PCR London Valves 2022

Consult this session on Valve-in-valve TAVI to discover a selection of cases presented during PCR LV 2022: valve-in-valve TAVR status post ascending aorta and aortic arch replacement, valve-in-valve and endovascular treatment of aortic dissection in a Marfan patient, valve-in-valve TAVR in a freestyle root 25 mm through a severely...

Valve-in-valve TAVI: Session 2

TAVI in complex situations - LIVE case

28 Nov 2022 – From PCR London Valves 2022

  • Part 1: TAVI with the presence of a mechanical mitral valve.
    An 80-year-old female with a history of mechanical mitral valve (25 On-X in 2015) presents severe symptomatic AS with preserved LV function. The operators implant a 25 mm Navitor, with predilatation (18 mm balloon) on wire pacing...
Transcatheter intervention for aortic valve disease: state of the art

Mitral complications

28 Nov 2022 – From PCR London Valves 2022

Because we can all be confronted with unexpected complications, this session of PCR LV 2022 proposes to study 5 specific cases such as an early redo mitral transcatheter edge-to-edge repair after single leaflet detachment or an unexpected cause of worsening dyspnoea after edge-to-edge mitral repair.

Mitral complications

Transcatheter mitral valve interventions: clinical outcomes 2

28 Nov 2022 – From PCR London Valves 2022

This PCR LV 2022 session will enable you to discover outcomes of transcatheter edge-to-edge MVR in patients with right ventricle dysfunction, TEER for MR early after myocardial infarction, or a predictive selection of patients for TMVR, among others!

Transcatheter mitral valve interventions: clinical outcomes 2

TAVI: technical considerations

28 Nov 2022 – From PCR London Valves 2022

Consult this session on TAVI technical considerations to discover a selection of cases presented during PCR LV 2022: transseptal snaring as a bailout from valvuloplasty balloon entrapment within a self-expanding valve, severe thrombocytopenia and severe aortic stenosis, embolisation of a fully deployed Evolute valve due to chest...

TAVI: technical considerations
Didn’t find what you were looking for?